Scientists are urging caution about a common ingredient found in semaglutide and ozempic, although the specific concerns and potential health impacts are unclear. Some reports suggest a possible link to lung cancer in non-smokers under 50, while others mention unrelated issues such as planetary health concerns and autism risk. The exact nature of the warning and the ingredient in question are not specified, leading to uncertainty about the potential risks.